MEDICUS PHARMA LTD. Basic Shares Outstanding (Weighted Average)
MEDICUS PHARMA LTD. (MDCX) reported Basic Shares Outstanding (Weighted Average) of 55.06 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- MEDICUS PHARMA LTD. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 55.06M shares, a 285.43% increase year-over-year.
- MEDICUS PHARMA LTD. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 29.54M shares, a 141.34% increase year-over-year.
- MEDICUS PHARMA LTD. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 18.60M shares, a 63.67% increase year-over-year.
- MEDICUS PHARMA LTD. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 18.63M shares, a 95.82% increase year-over-year.
- MEDICUS PHARMA LTD. weighted average number of shares outstanding, basic for fiscal 2025 was 17.28M shares, a 79.68% increase from fiscal 2024.
- MEDICUS PHARMA LTD. weighted average number of shares outstanding, basic for fiscal 2024 was 9.62M shares, a 176.45% increase from fiscal 2023.
- MEDICUS PHARMA LTD. weighted average number of shares outstanding, basic for fiscal 2023 was 3.48M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 55.06M shares 10-Q · filed 2026-08-12 | 47.57M shares 10-Q · filed 2026-08-12 | 34.40M shares derived: average of 3 quarters · filed 2026-08-12 | 30.46M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 29.54M shares 10-Q · filed 2026-05-14 | 24.07M shares derived: average of 2 quarters · filed 2026-05-14 | 22.26M shares derived: average of 3 quarters · filed 2026-05-14 | 20.26M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 18.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 18.62M shares derived: average of 2 quarters · filed 2026-03-25 | 17.17M shares derived: average of 3 quarters · filed 2026-08-12 | 17.28M shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 18.63M shares 10-Q · filed 2025-11-14 | 16.46M shares derived: average of 2 quarters · filed 2026-08-12 | 16.84M shares 10-Q · filed 2025-11-14 | 14.13M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 14.28M shares 10-Q · filed 2026-08-12 | 13.85M shares 10-Q · filed 2026-08-12 | 12.63M shares derived: average of 3 quarters · filed 2026-08-12 | 11.85M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 12.24M shares 10-Q · filed 2026-05-14 | 11.80M shares derived: average of 2 quarters · filed 2026-05-14 | 11.04M shares derived: average of 3 quarters · filed 2026-05-14 | 10.32M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 11.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 10.44M shares derived: average of 2 quarters · filed 2026-03-25 | 9.68M shares derived: average of 3 quarters · filed 2026-03-25 | 9.62M shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 9.51M shares 10-Q · filed 2025-11-14 | 8.84M shares derived: average of 2 quarters · filed 2025-11-14 | 9.04M shares 10-Q · filed 2025-11-14 | |
| 2024-06-30 | 8.17M shares 10-Q · filed 2025-08-11 | 8.12M shares 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | 8.08M shares 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | 3.48M shares 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |